BrightSpring Health Services (NASDAQ:BTSG) Price Target Raised to $84.00

BrightSpring Health Services (NASDAQ:BTSG) had its price objective boosted by analysts at Guggenheim from $81.00 to $84.00 in a report issued on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Guggenheim‘s target price suggests a potential upside of 25.41% from the stock’s current price.

Other analysts also recently issued reports about the stock. BTIG Research restated a “buy” rating and issued a $90.00 target price on shares of BrightSpring Health Services in a report on Thursday, August 13th. Raymond James Financial began coverage on shares of BrightSpring Health Services in a report on Thursday, July 9th. They issued an “outperform” rating and a $80.00 price target for the company. BMO Capital Markets reaffirmed an “outperform” rating on shares of BrightSpring Health Services in a report on Friday, October 2nd. Wells Fargo & Company lifted their price target on BrightSpring Health Services from $78.00 to $82.00 and gave the stock an “overweight” rating in a research report on Monday. Finally, Leerink Partners boosted their price objective on BrightSpring Health Services from $72.00 to $92.00 and gave the stock an “outperform” rating in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, BrightSpring Health Services has a consensus rating of “Buy” and a consensus price target of $77.81.

BrightSpring Health Services Trading Up 1.1%

Shares of BTSG opened at $66.98 on Tuesday. The company’s fifty day moving average is $60.09 and its 200 day moving average is $54.68. BrightSpring Health Services has a fifty-two week low of $30.64 and a fifty-two week high of $73.75. The stock has a market capitalization of $13.25 billion, a PE ratio of 36.04, a P/E/G ratio of 0.77 and a beta of 1.87. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.22 and a current ratio of 1.59.

BrightSpring Health Services (NASDAQ:BTSG) last released its quarterly earnings results on Friday, October 30th. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.07. BrightSpring Health Services had a net margin of 2.55% and a return on equity of 16.73%. The company had revenue of $4.21 billion for the quarter, compared to the consensus estimate of $3.88 billion. The business’s revenue was up 26.4% on a year-over-year basis. Sell-side analysts expect that BrightSpring Health Services will post 1.64 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. TD Waterhouse Canada Inc. purchased a new position in BrightSpring Health Services during the 2nd quarter valued at about $22,054,000. Bank of America Corp DE increased its holdings in BrightSpring Health Services by 48.7% during the first quarter. Bank of America Corp DE now owns 1,534,154 shares of the company’s stock valued at $65,370,000 after buying an additional 502,786 shares during the period. Ausbil Investment Management Ltd purchased a new position in BrightSpring Health Services during the second quarter valued at approximately $2,005,000. Bellars Harris Wealth Management LLC bought a new position in BrightSpring Health Services in the second quarter worth approximately $4,394,000. Finally, Tidal Investments LLC raised its stake in BrightSpring Health Services by 186.2% in the second quarter. Tidal Investments LLC now owns 68,900 shares of the company’s stock worth $4,805,000 after buying an additional 44,828 shares in the last quarter.

Key Stories Impacting BrightSpring Health Services

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: UBS raised its price target to $92 from $85 and maintained a Buy rating, reinforcing the bullish analyst outlook. UBS raises BrightSpring price target
• Positive Sentiment: Leerink Partners lifted its target to $92 from $72 and upgraded its rating to Outperform, citing substantial potential upside from current levels. Leerink Partners BrightSpring rating
• Positive Sentiment: TD Cowen raised its target to $84 from $81 and assigned a Buy rating, while Wells Fargo increased its target to $82 from $78 and kept an Overweight rating. TD Cowen BrightSpring rating Wells Fargo BrightSpring rating
• Positive Sentiment: Third-quarter earnings reportedly beat expectations, with earnings up sharply as specialty pharmacy launches and home-health growth drove revenue gains, margin expansion and higher full-year guidance. Management also highlighted organic-growth opportunities for 2027. BrightSpring Q3 earnings beat
• Positive Sentiment: Wall Street Zen upgraded BrightSpring to Strong-Buy, adding to the series of positive analyst actions. Wall Street Zen BrightSpring upgrade
• Neutral Sentiment: At roughly 35.8 times earnings, BTSG is priced for continued execution. Its elevated beta also suggests potentially greater volatility as investors digest the earnings-driven rally.
• Negative Sentiment: With multiple price-target increases already reflected in recent strength, near-term profit-taking may be limiting further gains despite the favorable fundamental and analyst news.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ:BTSG) is a Louisville, Kentucky-based provider of home- and community-based health services and pharmacy services. The company focuses on supporting individuals with complex or chronic care needs, including older adults and people with disabilities, through care delivered in homes, communities and other non-hospital settings.

Its services include home health, hospice, personal care, behavioral health, primary care, rehabilitation and community living programs.